Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia

This study has been completed.
Sponsor:
Collaborators:
Information provided by (Responsible Party):
Pamela Hinton, University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT00572104
First received: December 10, 2007
Last updated: August 13, 2014
Last verified: August 2014
  Purpose

This study will compare the ability of two types of long term (12 months) weight-bearing exercise treatments (1. high-intensity jumping and 2. weight lifting) to increase bone mass of the total body, spine and hip in physically active men with osteopenia.


Condition Intervention
Osteopenia
Other: exercise intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia

Resource links provided by NLM:


Further study details as provided by University of Missouri-Columbia:

Primary Outcome Measures:
  • Bone Mineral Density [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Serum markers of bone turnover [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • Serum hormones regulating bone turnover [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 38
Study Start Date: January 2008
Study Completion Date: November 2013
Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
12 month resistance exercise training
Other: exercise intervention
12 month training intervention of either plyometrics or weight resistance exercise.
Other Name: All participants receive a daily calcium and vitamin D supplement
Experimental: 2
12 month plyometric exercise training
Other: exercise intervention
12 month training intervention of either plyometrics or weight resistance exercise.
Other Name: All participants receive a daily calcium and vitamin D supplement

  Eligibility

Ages Eligible for Study:   25 Years to 60 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male
  • Age 25-60 years
  • No symptoms of disease
  • Currently participating in cycling activities an average of 4 hr/wk for the previous 24 months
  • Osteopenia of the lumbar spine and/or hip (T score < -1.0 and > -2.5 )

Exclusion Criteria:

  • Medications or supplements that affect bone metabolism or prevent exercise
  • Previous or current medical condition affecting bone health
  • Osteoporosis of the lumbar spine and/or hip (T score > -1.0 or < -2.5)
  • Cardiovascular disease
  • Metallic implants
  • Current smoker
  • Current regular participation in high-intensity resistance training and/or plyometrics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00572104

Locations
United States, Missouri
University of Missouri-Columbia; McKee Gym
Columbia, Missouri, United States, 65211
Sponsors and Collaborators
University of Missouri-Columbia
Investigators
Principal Investigator: Pamela S Hinton University of Missouri-Columbia, Department of Nutritional Sciences
  More Information

No publications provided

Responsible Party: Pamela Hinton, Associate Professor of Nutrition and Exercise Physiology, University of Missouri-Columbia
ClinicalTrials.gov Identifier: NCT00572104     History of Changes
Other Study ID Numbers: 1095877, R03AR055738
Study First Received: December 10, 2007
Last Updated: August 13, 2014
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on September 18, 2014